Back to Search
KENNETH AIN, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1396857173Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
27682(KY)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
27682(KY)
Research & Publications (19)
Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas.
PMID 17696837·Thyroid·2007
3-trial
Pathobiology of antineoplastic therapy in undifferentiated thyroid cancer.
PMID 16209055·Cancer Treat Res·2004
6-review
Management of undifferentiated thyroid cancer.
PMID 11289738·Baillieres Best Pract Res Clin Endocrinol Metab·2000
6-review
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.
PMID 10958311·Thyroid·2000
3-trial
Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
PMID 17164311·J Clin Endocrinol Metab·2007
8-other
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
PMID 17199433·Thyroid·2006
4-observational
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
PMID 16849420·J Clin Endocrinol Metab·2006
8-other
Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro.
PMID 15126530·J Clin Endocrinol Metab·2004
8-other
Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
PMID 15157556·Clin Lab Med·2004
6-review
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
PMID 14676122·Clin Cancer Res·2003
8-other
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
PMID 12907632·Cancer Res·2003
8-other
Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors.
PMID 12593719·Thyroid·2002
7-preclinical
Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.
PMID 12485453·J Invest Dermatol·2002
7-preclinical
Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1.
PMID 11940046·Clin Endocrinol (Oxf)·2002
8-other
Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells.
PMID 11272092·Thyroid·2001
8-other
Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
PMID 11223914·J Neurosci Res·2001
7-preclinical
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
PMID 11114641·Surgery·2000
4-observational
American Thyroid Association guidelines for detection of thyroid dysfunction.
PMID 10847249·Arch Intern Med·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 740 S LIMESTONE
LEXINGTON, KY 40536 - Phone
- (859) 323-5821
Quick Facts
- NPI
- 1396857173
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile